세계의 가상 임상시험 참가자 아바타 시장 보고서(2025년)

Virtual clinical-trial participant avatars are digital representations of clinical trial participants designed to simulate human responses in trial scenarios. They allow researchers to model patient outcomes, optimize trial protocols, and predict potential risks before real-world testing. These avatars enhance efficiency by reducing reliance on physical participants and accelerating data-driven decision-making.

The primary types of virtual clinical-trial participant avatars are artificial intelligence-generated avatars, digitally modeled human avatars, and hybrid avatars. Artificial intelligence-generated avatars are software-created virtual participants that simulate real patient behaviors, responses, and physiological parameters using AI algorithms. Avatars are deployed via cloud-based or on-premises systems and are applied in drug development, patient recruitment, data simulation, remote monitoring, and other use cases. Key end-users include pharmaceutical companies, contract research organizations, academic and research institutes, and other healthcare organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The virtual clinical-trial participant avatars market research report is one of a series of new reports from The Business Research Company that provides virtual clinical-trial participant avatars market statistics, including virtual clinical-trial participant avatars industry global market size, regional shares, competitors with a virtual clinical-trial participant avatars market share, detailed virtual clinical-trial participant avatars market segments, market trends and opportunities, and any further data you may need to thrive in the virtual clinical-trial participant avatars industry. The virtual clinical-trial participant avatars market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The virtual clinical-trial participant avatars market size has grown exponentially in recent years. It will grow from $1.19 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 28.8%. Growth in the historic period was driven by rising adoption of decentralized clinical trials, increasing demand for patient diversity, growth in wearable health monitoring devices, regulatory support for digital trial solutions, and the need to reduce clinical trial timelines.

The virtual clinical-trial participant avatars market size is expected to see exponential growth in the next few years. It will grow to $4.18 billion in 2029 at a compound annual growth rate (CAGR) of 28.4%. Growth in the forecast period is expected to be supported by advancements in AI-driven patient simulation, integration of virtual avatars with electronic data capture systems, growing focus on personalized medicine, increased investment in digital twin technologies, and expansion of virtual trials for rare diseases and chronic conditions. Key trends anticipated for the forecast period include the use of AI-powered digital twins for patient simulation, integration of real-world data and electronic health records, adoption of machine learning for predictive trial outcomes, development of immersive VR/AR platforms for patient engagement, and implementation of blockchain for secure patient data management.

The increasing number of clinical trials is expected to drive the expansion of the virtual clinical-trial participant avatars market in the coming years. Clinical trials are structured studies that assess the safety and effectiveness of medical treatments in human subjects. The rise in clinical trials is fueled by growing investments from pharmaceutical companies in drug development, as they work to create new therapies for complex diseases and personalized medicine. Virtual clinical-trial participant avatars use artificial intelligence to create digital patient models that simulate how diseases progress, how treatments respond, and potential safety outcomes. These models help accelerate patient recruitment, improve trial design, detect effective therapies earlier, and reduce costs and risks. For example, in November 2023, the Association of the British Pharmaceutical Industry, a trade association based in the United Kingdom, reported that industry-sponsored clinical trials launched annually in the UK grew by 4.3 percent, increasing from 394 trials in 2021 to 411 trials in 2022. Thus, the rising number of clinical trials is contributing to growth in the virtual clinical-trial participant avatars market.

Key players in the virtual clinical-trial participant avatars market are developing advanced solutions such as digital twin-based clinical trial participants to boost trial efficiency and improve the accuracy of drug development predictions. Digital twin-based clinical trial participants are virtual replicas of actual patients that mimic their physiological and behavioral responses, allowing researchers to forecast treatment effects and optimize trial designs while reducing the need for extensive physical testing. For instance, in July 2023, Unlearn.ai, Inc., a United States-based company specializing in AI clinical trial technology, launched version 3.1 of its digital twin generator for Alzheimer's disease. This update enhanced the handling of missing baseline data by integrating a neural network imputation model within a Neural Boltzmann Machine framework, which reduced sensitivity to missing information and improved overall performance. The generator utilizes diverse patient datasets to produce personalized digital twins that can accurately predict clinical and biomarker progression, supporting clinical trials with more precise modeling of Alzheimer's disease.

In August 2023, Altis Labs, Inc., a Canada-based provider of AI-generated digital twins representing patients in clinical trials, formed a partnership with AstraZeneca and Bayer Pharmaceuticals to accelerate clinical trial processes using AI-driven patient-specific digital twins. This collaboration focuses on employing AI-powered digital twins to simulate disease progression and treatment outcomes, thereby improving trial efficiency, lowering failure rates, and prioritizing promising cancer treatments. AstraZeneca is a pharmaceutical company based in the United Kingdom, while Bayer Pharmaceuticals is headquartered in Germany.

Major players in the virtual clinical-trial participant avatars market are NVIDIA Corporation, Dassault Systemes SE, Signant Health Holding Corp., Owkin Inc, Medable Inc., Insilico Medicine Inc., Science 37 Inc., THREAD Inc., Lindus Health Limited, Obvio Health, Sano Genetics Limited, GNS Healthcare, Unlearn.ai Inc., Novadiscovery SAS, Deep 6 AI, Ai Cure Technologies, Altis Labs Inc., Physiomics Plc, OneThree Biotech, Aitia Bio.

North America was the largest region in the virtual clinical-trial participant avatars market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in virtual clinical-trial participant avatars report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the virtual clinical-trial participant avatars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The virtual clinical-trial participant avatars market includes revenues earned by entities by providing services such as patient simulation, data modeling, pharmacokinetic prediction, virtual trial design, and safety assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virtual Clinical-Trial Participant Avatars Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on virtual clinical-trial participant avatars market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for virtual clinical-trial participant avatars ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The virtual clinical-trial participant avatars market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Avatar Type: Artificial Intelligence-Generated Avatars; Digitally Modeled Human Avatars; Hybrid Avatars
• 2) By Deployment Mode: Cloud-Based; On-Premises
• 3) By Application: Drug Development; Patient Recruitment; Data Simulation; Remote Monitoring; Other Applications
• 4) By End-User: Pharmaceutical Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users
• Subsegments:
• 1) By Artificial Intelligence-Generated Avatars: Machine Learning-Based Avatars; Deep Learning-Based Avatars; Natural Language Processing (NLP)-Enabled Avatars; Generative Adversarial Network (GAN)-Based Avatars
• 2) By Digitally Modeled Human Avatars: Three-Dimensional (3D) Scanned Human Avatars; Motion Capture Modeled Avatars; Photorealistic Rendered Avatars; Anatomically Accurate Human Avatars
• 3) By Hybrid Avatars: Artificial Intelligence (AI)-Enhanced Digitally Modeled Avatars; Mixed Reality (MR) Enabled Avatars; Cognitive Simulation Avatars; Sensor-Integrated Virtual Avatars
• Companies Mentioned: NVIDIA Corporation; Dassault Systemes SE; Signant Health Holding Corp.; Owkin Inc; Medable Inc.; Insilico Medicine Inc.; Science 37 Inc.; THREAD Inc.; Lindus Health Limited; Obvio Health; Sano Genetics Limited; GNS Healthcare; Unlearn.ai Inc.; Novadiscovery SAS; Deep 6 AI; Ai Cure Technologies; Altis Labs Inc.; Physiomics Plc; OneThree Biotech; Aitia Bio
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Virtual Clinical-Trial Participant Avatars Market Characteristics

3. Virtual Clinical-Trial Participant Avatars Market Trends And Strategies

4. Virtual Clinical-Trial Participant Avatars Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Virtual Clinical-Trial Participant Avatars Growth Analysis And Strategic Analysis Framework

• 5.1. Global Virtual Clinical-Trial Participant Avatars PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Virtual Clinical-Trial Participant Avatars Market Growth Rate Analysis
• 5.4. Global Virtual Clinical-Trial Participant Avatars Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Virtual Clinical-Trial Participant Avatars Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Virtual Clinical-Trial Participant Avatars Total Addressable Market (TAM)

6. Virtual Clinical-Trial Participant Avatars Market Segmentation

• 6.1. Global Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artificial Intelligence-Generated Avatars
• Digitally Modeled Human Avatars
• Hybrid Avatars
• 6.2. Global Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based
• On-Premises
• 6.3. Global Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Development
• Patient Recruitment
• Data Simulation
• Remote Monitoring
• Other Applications
• 6.4. Global Virtual Clinical-Trial Participant Avatars Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Contract Research Organizations
• Academic And Research Institutes
• Other End-Users
• 6.5. Global Virtual Clinical-Trial Participant Avatars Market, Sub-Segmentation Of Artificial Intelligence-Generated Avatars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Machine Learning-Based Avatars
• Deep Learning-Based Avatars
• Natural Language Processing (NLP)-Enabled Avatars
• Generative Adversarial Network (GAN)-Based Avatars
• 6.6. Global Virtual Clinical-Trial Participant Avatars Market, Sub-Segmentation Of Digitally Modeled Human Avatars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Three-Dimensional (3D) Scanned Human Avatars
• Motion Capture Modeled Avatars
• Photorealistic Rendered Avatars
• Anatomically Accurate Human Avatars
• 6.7. Global Virtual Clinical-Trial Participant Avatars Market, Sub-Segmentation Of Hybrid Avatars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artificial Intelligence (AI)-Enhanced Digitally Modeled Avatars
• Mixed Reality (MR) Enabled Avatars
• Cognitive Simulation Avatars
• Sensor-Integrated Virtual Avatars

7. Virtual Clinical-Trial Participant Avatars Market Regional And Country Analysis

• 7.1. Global Virtual Clinical-Trial Participant Avatars Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Virtual Clinical-Trial Participant Avatars Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Virtual Clinical-Trial Participant Avatars Market

• 8.1. Asia-Pacific Virtual Clinical-Trial Participant Avatars Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Virtual Clinical-Trial Participant Avatars Market

• 9.1. China Virtual Clinical-Trial Participant Avatars Market Overview
• 9.2. China Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Virtual Clinical-Trial Participant Avatars Market

• 10.1. India Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Virtual Clinical-Trial Participant Avatars Market

• 11.1. Japan Virtual Clinical-Trial Participant Avatars Market Overview
• 11.2. Japan Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Virtual Clinical-Trial Participant Avatars Market

• 12.1. Australia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Virtual Clinical-Trial Participant Avatars Market

• 13.1. Indonesia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Virtual Clinical-Trial Participant Avatars Market

• 14.1. South Korea Virtual Clinical-Trial Participant Avatars Market Overview
• 14.2. South Korea Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Virtual Clinical-Trial Participant Avatars Market

• 15.1. Western Europe Virtual Clinical-Trial Participant Avatars Market Overview
• 15.2. Western Europe Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Virtual Clinical-Trial Participant Avatars Market

• 16.1. UK Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Virtual Clinical-Trial Participant Avatars Market

• 17.1. Germany Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Virtual Clinical-Trial Participant Avatars Market

• 18.1. France Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Virtual Clinical-Trial Participant Avatars Market

• 19.1. Italy Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Virtual Clinical-Trial Participant Avatars Market

• 20.1. Spain Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Virtual Clinical-Trial Participant Avatars Market

• 21.1. Eastern Europe Virtual Clinical-Trial Participant Avatars Market Overview
• 21.2. Eastern Europe Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Virtual Clinical-Trial Participant Avatars Market

• 22.1. Russia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Virtual Clinical-Trial Participant Avatars Market

• 23.1. North America Virtual Clinical-Trial Participant Avatars Market Overview
• 23.2. North America Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Virtual Clinical-Trial Participant Avatars Market

• 24.1. USA Virtual Clinical-Trial Participant Avatars Market Overview
• 24.2. USA Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Virtual Clinical-Trial Participant Avatars Market

• 25.1. Canada Virtual Clinical-Trial Participant Avatars Market Overview
• 25.2. Canada Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Virtual Clinical-Trial Participant Avatars Market

• 26.1. South America Virtual Clinical-Trial Participant Avatars Market Overview
• 26.2. South America Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Virtual Clinical-Trial Participant Avatars Market

• 27.1. Brazil Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Virtual Clinical-Trial Participant Avatars Market

• 28.1. Middle East Virtual Clinical-Trial Participant Avatars Market Overview
• 28.2. Middle East Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Virtual Clinical-Trial Participant Avatars Market

• 29.1. Africa Virtual Clinical-Trial Participant Avatars Market Overview
• 29.2. Africa Virtual Clinical-Trial Participant Avatars Market, Segmentation By Avatar Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Virtual Clinical-Trial Participant Avatars Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Virtual Clinical-Trial Participant Avatars Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Virtual Clinical-Trial Participant Avatars Market Competitive Landscape And Company Profiles

• 30.1. Virtual Clinical-Trial Participant Avatars Market Competitive Landscape
• 30.2. Virtual Clinical-Trial Participant Avatars Market Company Profiles
  • 30.2.1. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Signant Health Holding Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Owkin Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medable Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Virtual Clinical-Trial Participant Avatars Market Other Major And Innovative Companies

• 31.1. Insilico Medicine Inc.
• 31.2. Science 37 Inc.
• 31.3. THREAD Inc.
• 31.4. Lindus Health Limited
• 31.5. Obvio Health
• 31.6. Sano Genetics Limited
• 31.7. GNS Healthcare
• 31.8. Unlearn.ai Inc.
• 31.9. Novadiscovery SAS
• 31.10. Deep 6 AI
• 31.11. Ai Cure Technologies
• 31.12. Altis Labs Inc.
• 31.13. Physiomics Plc
• 31.14. OneThree Biotech
• 31.15. Aitia Bio

32. Global Virtual Clinical-Trial Participant Avatars Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Virtual Clinical-Trial Participant Avatars Market

34. Recent Developments In The Virtual Clinical-Trial Participant Avatars Market

35. Virtual Clinical-Trial Participant Avatars Market High Potential Countries, Segments and Strategies

• 35.1 Virtual Clinical-Trial Participant Avatars Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Virtual Clinical-Trial Participant Avatars Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Virtual Clinical-Trial Participant Avatars Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer